The Future of Direct-to-Consumer Genetic Testing: Regulation and Innovation

Download Full Text PDF

Volume 16, Online Edition (Jan 2015)

Direct-to-consumer (“DTC”) genetic testing companies face regulation from numerous parties. The Food and Drug Administration has taken the lead role in the regulation of this industry. The Federal Trade Commission must make sure that consumers are not misled by unscrupulous marketing and false advertising. The Centers for Medicare and Medicaid Services under the Clinical Laboratory Improvement Amendments should ensure that genetic tests are analytically and clinically valid. State laws and federal statutes like the Genetic Information Discrimination Act address consumer privacy concerns. The recent Molecular Pathology v. Myriad Genetics, Inc. Supreme Court decision will shape the direction of DTC genetic testing patents. Case law is also influencing DTC genetic consumer protection. These various regulatory mechanisms must strike a balance between protecting DTC genetic test consumers without stifling important innovations in this industry.

Chelsea Weiermiller, The Future of Direct-to-Consumer Genetic Testing: Regulation and Innovation 16 N.C. J.L. & Tech. On. 137 (2014), available at http://ncjolt.org/wp-content/uploads/2015/01/Weiermiller_Final.pdf

The North Carolina Journal of Law & Technology has adopted the Open Access Program, a part of the Scholar’s Copyright Project created by Science Commons. Authors designate the conditions under which their articles are licensed. By downloading articles, you agree to comply with the license terms specified. Please contact NC JOLT at eic.ncjolt@gmail.com with permissions inquiries.